Abstract
Completion of the Human Genome Project has helped in identifying disease genes, particularly with regard to mapping high-density single nucleotide polymorphisms and development of high-throughput genotyping platforms, which have considerably advanced research on complex disorders. Genome-wide searches are now practical and led to identification of genetic variations within previously unexamined genes relevant to diseases. In a genome-wide linkage study, the author and colleagues discovered that ITPKC and CASP3 are common susceptibility genes for Kawasaki disease. This prompted examination of the Ca2+/NFAT pathway and a subsequent continuous series of newly identified Kawasaki disease susceptibility genes. The recent identification of the FCGR2A, BLK, CD40, and HLA class II gene regions in genome-wide association studies has shed new light on the pathogenesis of Kawasaki disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Onouchi Y. Molecular genetics of Kawasaki disease. Pediatr Res. 2009;65(5 Pt 2):46R–54. http://dx.doi.org/10.1203/PDR.0b013e31819dba60 PMID:19190534.
Onouchi Y, Gunji T, Burns JC, Shimizu C, Newburger JW, Yashiro M, et al. ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet. 2008;40(1):35–42. http://dx.doi.org/10.1038/ng.2007.59 PMID:18084290.
Onouchi Y, Tamari M, Takahashi A, Tsunoda T, Yashiro M, Nakamura Y, et al. A genomewide linkage analysis of Kawasaki disease: evidence for linkage to chromosome 12. J Hum Genet. 2007;52(2):179–90. http://dx.doi.org/10.1007/s10038-006-0092-3 PMID:17160344.
Lou J, Xu S, Zou L, Zhong R, Zhang T, Sun Y, et al. A functional polymorphism, rs28493229, in ITPKC and risk of Kawasaki disease: an integrated meta-analysis. Mol Biol Rep. 2012;39(12):11137–44. http://dx.doi.org/10.1007/s11033-012-2022-0 PMID:23065250.
Khor CC, Davila S, Breunis WB, Lee YC, Shimizu C, Wright VJ, Hong Kong–Shanghai Kawasaki Disease Genetics Consortium, Korean Kawasaki Disease Genetics Consortium, Taiwan Kawasaki Disease Genetics Consortium, International Kawasaki Disease Genetics Consortium, US Kawasaki Disease Genetics Consortium, Blue Mountains Eye Study, et al. Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat Genet. 2011;43(12):1241–6. http://dx.doi.org/10.1038/ng.981 PMID:22081228.
Onouchi Y, Ozaki K, Buns JC, Shimizu C, Hamada H, Honda T, et al. Common variants in CASP3 confer susceptibility to Kawasaki disease. Hum Mol Genet. 2010;19(14):2898–906. http://dx.doi.org/10.1093/hmg/ddq176 PMID:20423928.
Xing Y, Wang H, Liu X, Yu X, Chen R, Wang C, et al. Meta-analysis of the relationship between single nucleotide polymorphism rs72689236 of caspase-3 and Kawasaki disease. Mol Biol Rep. 2014;41(10):6377–81. http://dx.doi.org/10.1007/s11033-014-3517-7 PMID:24990693.
Duan J, Lou J, Zhang Q, Ke J, Qi Y, Shen N, et al. A genetic variant rs1801274 in FCGR2A as a potential risk marker for Kawasaki disease: a case-control study and meta-analysis. PLoS One. 2014;9(8):e103329. http://dx.doi.org/10.1371/journal.pone.0103329 PMID:25093412.
Onouchi Y, Ozaki K, Burns JC, Shimizu C, Terai M, Hamada H, Japan Kawasaki Disease Genome Consortium, US Kawasaki Disease Genetics Consortium, et al. A genome-wide association study identifies three new risk loci for Kawasaki disease. Nat Genet. 2012;44(5):517–21. http://dx.doi.org/10.1038/ng.2220 PMID:22446962.
Lee YC, Kuo HC, Chang JS, Chang LY, Huang LM, Chen MR, Taiwan Pediatric ID Alliance, et al. Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis. Nat Genet. 2012;44(5):522–5. http://dx.doi.org/10.1038/ng.2227 PMID:22446961.
Suzuki H, Terai M, Hamada H, Honda T, Suenaga T, Takeuchi T, et al. Cyclosporin A treatment for Kawasaki disease refractory to initial and additional intravenous immunoglobulin. Pediatr Infect Dis J. 2011;30(10):871–6. http://dx.doi.org/10.1097/INF.0b013e318220c3cf PMID:21587094.
Tremoulet AH, Pancoast P, Franco A, Bujold M, Shimizu C, Onouchi Y, et al. Calcineurin inhibitor treatment of intravenous immunoglobulin-resistant Kawasaki disease. J Pediatr. 2012;161(3):506–12 e1.
Onouchi Y, Suzuki Y, Suzuki H, Terai M, Yasukawa K, Hamada H, et al. ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease. Pharmacogenomics J. 2013;13(1):52–9. http://dx.doi.org/10.1038/tpj.2011.45 PMID:21987091.
Hom G, Graham RR, Modrek B, Taylor KE, Ortmann W, Garnier S, et al. Association of systemic lupus erythematosus with C8orf13-BLK and ITGAM-ITGAX. N Engl J Med. 2008;358(9):900–9. http://dx.doi.org/10.1056/NEJMoa0707865 PMID:18204098.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Japan
About this chapter
Cite this chapter
Onouchi, Y. (2017). Identification of Novel Kawasaki Disease Susceptibility Genes by Genome-Wide Association Studies. In: Saji, B., Newburger, J., Burns, J., Takahashi, M. (eds) Kawasaki Disease. Springer, Tokyo. https://doi.org/10.1007/978-4-431-56039-5_4
Download citation
DOI: https://doi.org/10.1007/978-4-431-56039-5_4
Published:
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-56037-1
Online ISBN: 978-4-431-56039-5
eBook Packages: MedicineMedicine (R0)